Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01487161 · ClinicalTrials.gov registry record · Phase 2
Study of FX006 in Patients With Osteoarthritis of the Knee
A Phase 2 study, sponsored by Pacira Pharmaceuticals.
- Completed
- Registry status
- Phase 2
- Development phase
- 229
- Enrollment target
NCT01487161 is a Phase 2 study that has completed, run by Pacira Pharmaceuticals. The registered enrollment target is 229 participants.
The verdict
NCT01487161, a Phase 2 study, has completed, sponsored by Pacira Pharmaceuticals.
- COMPLETED
- Registry status
- Phase 2
- Development phase
- 229 participants
- Enrollment target
Study Summary
The purpose of this study was to evaluate the safety, efficacy and pharmacokinetics of FX006 in patients with osteoarthritis of the knee.
Interventions
- DRUG FX006
- DRUG TCA IR
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 229 participants |
| Start Date | 2012-06 |
| Est. Completion | 2013-04 |
| Phase | Phase 2 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT01487161
The ClinicalTrials.gov registry entry for NCT01487161 describes a study currently listed as completed, categorized as Phase 2. The registered enrollment target is 229 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Pacira Pharmaceuticals, which has 88 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 2 interventions - of which FX006 is the first listed.
NCT01487161 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT01487161 about?
NCT01487161 is a clinical study titled "Study of FX006 in Patients With Osteoarthritis of the Knee". The purpose of this study was to evaluate the safety, efficacy and pharmacokinetics of FX006 in patients with osteoarthritis of the knee.
What is the current status of trial NCT01487161?
This trial is currently completed. It is a Phase 2 study. The enrollment target is 229 participants. The study started on 2012-06. Estimated completion is 2013-04.
What interventions are being tested in trial NCT01487161?
The interventions under investigation include: FX006 (DRUG), TCA IR (DRUG).
Who is sponsoring clinical trial NCT01487161?
This trial is sponsored by Pacira Pharmaceuticals, which has 88 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.